SHZ · 002001.SZ
Zhejiang NHU Company Ltd.
CN¥25.73+CN¥0.29 (+1.14%)
Zhejiang NHU Company Ltd.’s quoted price sits in the lower half of its reported 52-week range, 35.98% below the high.
Loading market information…
SHZ · 301015.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:12 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Qingdao Baheal Medical Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.28% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Qingdao Baheal Medical Inc.’s forward annual dividend is CN¥0.57 per share, paid annual. The forward yield is 2.11% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Qingdao Baheal Medical Inc.’s next earnings report is currently expected on Apr 27, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Qingdao Baheal Medical Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Qingdao Baheal Medical Inc., established in 2005 and headquartered in Qingdao, China, operates as a pharmaceutical company. The firm's activities encompass the entire spectrum of drug development, from initial research to manufacturing and sales of various medicinal products. A key offering in its portfolio is vitamin D calcium in chewable tablet form.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | Apr 23, 2025 | CN¥0.16 | CN¥1.84B-0.01% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥25.73+CN¥0.29 (+1.14%)
Zhejiang NHU Company Ltd.’s quoted price sits in the lower half of its reported 52-week range, 35.98% below the high.
CN¥34.32-CN¥0.66 (-1.89%)
CSPC Innovation Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.72% below the high.
CN¥10.00+CN¥0.14 (+1.42%)
By-health Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 24.24% below the high.
CN¥10.71+CN¥0.10 (+0.94%)
Zhejiang Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 42.36% below the high.
CN¥12.19+CN¥0.15 (+1.25%)
Zhejiang Garden Biopharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.74% below the high.
CN¥4.42+CN¥0.09 (+2.08%)
Northeast Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.46% below the high.
CN¥16.95+CN¥0.39 (+2.36%)
Sirio Pharma Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 35.23% below the high.
CN¥21.42-CN¥2.38 (-10.0%)
Shandong Wit Dyne Health Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.76% below the high.
